A Randomized Controlled Trial Examining the Impact of an Anorectal Surgery Multimodal Enhanced Recovery Program on Opioid Use. Issue 1 (January 2022)

• Record Type: Journal Article
• Authors: Reif de Paula, Thais; Nemeth, Samantha K.; Kurlansky, Paul A.; Simon, Hillary L.; Miller, Lydia K.; Keller, Deborah S.
• Is Part Of: Annals of surgery. Volume 275:Issue 1(2022)
• Publication Date: 2022-01
• Subjects: anorectal surgery -- colorectal surgery -- enhanced recovery after surgery (ERAS -- ERP) -- new persistent opioid use -- opioid epidemic -- opioids; Surgery -- Periodicals; 617.005
• DOI: 10.1097/SLA.0000000000004701
• Languages: English
• ISSNs: 0003-4932

Abstract

Abstract : Background: Anorectal cases may be a common gateway to the opioid epidemic. Opioid reduction is inherent in enhanced recovery after surgery (ERAS) protocols, but little work has evaluated ERAS in these cases. Objective: To determine if ERAS could reduce postoperative opioid utilization in ambulatory anorectal surgery without sacrificing patient pain or satisfaction. Methods: A randomized controlled trial assigned ambulatory anorectal patients to ERAS (experimental) or routine care (surgeon's choice) for pain management (control) over 30-days postoperatively. Primary outcome was overall days of opioid use. Secondary outcomes included pain and satisfaction scores over multiple time points and new persistent opioid use. The Visual Analog Scale, Functional Pain Scale, and EQ-5D-3L measured patient-reported pain and satisfaction. Univariate analysis compared outcomes overall and at individual time points. Two-way mixed ANOVA evaluated pain and satisfaction measures between groups and over time. Results: Thirty-two patients were randomized into each arm (64 total). The control group consumed significantly more opioids after discharge (median 121.3MME vs 23.5MME, P < 0.001). Significantly more control patients requested additional narcotics ( P = 0.004), made unplanned calls ( P = 0.009), and had unplanned clinic visits ( P = 0.003). The control group had significantly more days on opioids (mean 14.4 vs 2.2, P < 0.001). Three control patients (9.4%) versus no experimental patients had new persistent opioid use. The mean global health, EQ5D-3L, Visual Analog Scale, and Functional Pain scores were comparable between groups over time. Conclusions: An ERAS protocol in ambulatory anorectal surgery is feasible, and resulted in reduced opioid use, and healthcare utilization, with no difference in pain or patient satisfaction. This challenges the paradigm that extended opioids are needed for effective postoperative pain management. Abstract : Supplemental Digital Content is available in the text